Gene therapy of the brain in the dog model of Hurler's syndrome.
Carine C Ciron,
Nathalie N Desmaris,
Marie-Anne MA Colle,
Sylvie S Raoul,
Béatrice B Joussemet,
Lucie L Vérot,
Jérôme J Ausseil,
Roseline R Froissart,
Françoise F Roux,
Yan Y Chérel,
Nicolas N Ferry,
Yaouen Y Lajat,
Bertrand B Schwartz,
Marie-Thérèse MT Vanier,
Irène I Maire,
Marc M Tardieu,
Philippe P Moullier and
Jean-Michel JM Heard
Ann Neurol 60(2):204-13 (2006)
PMID 16718701
A defect of the lysosomal enzyme alpha-L-iduronidase (IDUA) interrupts the degradation of glycosaminoglycans in mucopolysaccharidosis type I, causing severe neurological manifestations in children with Hurler's syndrome. Delivery of the missing enzyme through stereotactic injection of adeno-associated virus vectors coding for IDUA prevents neuropathology in affected mice. We examined the efficacy and the safety of this approach in enzyme-deficient dogs.
DOI: 10.1002/ana.20870
Version: za2963e q8zaa q8zb0 q8zc5 q8zdd q8zea q8zf9 q8zg5